[Hormonal desintegration in metabolic syndrome]

Area of Science:

• Endocrinology
• Metabolic Disorders
• Cardiovascular Physiology

Background:

• Metabolic syndrome (MS) is a complex condition characterized by a cluster of cardiovascular and metabolic risk factors.
• Hormonal dysregulation is increasingly implicated in the pathophysiology of MS, but specific interactions require further elucidation.
• Understanding these hormonal dynamics is crucial for developing targeted therapeutic strategies.

Purpose of the Study:

• To investigate hormonal disintegration in patients diagnosed with metabolic syndrome (MS).
• To analyze the influence of key hormones including insulin, leptin, cortisol, testosterone, and estradiol on MS development.
• To explore the relationship between insulin sensitivity, sympathetic nervous system activity, and arterial pressure in MS.

Main Methods:

• Utilized the Clamp-test to assess insulin dynamics and sensitivity.
• Employed computer tomography for comprehensive patient examination.
• Monitored and analyzed the levels of insulin, leptin, cortisol, testosterone, and estradiol in 27 healthy individuals and 38 MS patients.

Main Results:

• Demonstrated the significant influence of hyperinsulinemia, insulin resistance, and fluctuations in leptin and cortisol levels on MS progression.
• Identified probable mechanisms of hormonal interactions underlying the pathological processes in MS.
• Showed a direct correlation between insulin sensitivity, sympathetic nervous system activity, and elevated arterial pressure in MS patients.

Conclusions:

• Hormonal imbalances, particularly involving insulin, leptin, and cortisol, play a critical role in the development and progression of metabolic syndrome.
• Insulin resistance significantly impacts sympathetic nervous system function and contributes to hypertension in individuals with MS.
• Further research into these hormonal interactions may reveal novel therapeutic targets for managing metabolic syndrome and its associated complications.